Granahan Investment Management, LLC Apellis Pharmaceuticals, Inc. Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

A detailed history of Granahan Investment Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 150,578 shares of APLS stock, worth $4.99 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

150,578

Previous 122,383 23.04%

Holding current value

$4.99 Million

Previous $4.69 Million 7.5%

% of portfolio

0.18%

Previous 0.2%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $813,143 - $1.16 Million	28,195 Added 23.04%	150,578 $4.34 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $2.12 Million - $3.33 Million	55,786 Added 83.77%	122,383 $4.69 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $1.35 Million - $1.77 Million	24,356 Added 57.66%	66,597 $3.91 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $1.26 Million - $2.2 Million	-33,879 Reduced 44.51%	42,241 $2.53 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $890,540 - $3.36 Million	-37,655 Reduced 33.1%	76,120 $2.9 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $3.81 Million - $4.64 Million	-49,676 Reduced 30.39%	113,775 $10.4 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $887,865 - $1.28 Million	-19,057 Reduced 10.44%	163,451 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $1.98 Million - $2.79 Million	45,773 Added 33.48%	182,508 $9.44 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $217,399 - $338,338	-4,857 Reduced 3.43%	136,735 $9.34 Million
Q2 2022 Aug 15, 2022	SELL	$35.07 - $59.21 $432,448 - $730,118	-12,331 Reduced 8.01%	141,592 $6.4 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $2.49 Million - $3.81 Million	70,322 Added 84.12%	153,923 $7.82 Million
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $2.57 Million - $4.11 Million	83,601 New	83,601 $3.95 Million

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account

Granahan Investment Management, LLC Apellis Pharmaceuticals, Inc. Transaction History